NEW YORK (GenomeWeb News) – JumpStart, a non-profit venture development organization based in Cleveland, said on Tuesday it is committing $250,000 to GenomOncology, an Ohio-based startup developing tools and software for analyzing genomic sequencing data for clinical applications.

GenomOncology's technology is designed to detect and analyze genetic mutations, and the Westlake, Ohio-based company plans to be a one-stop shop for analyzing large volumes of data and turning it into useful information for clinicians, said JumpStart.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.

Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."